• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Grand Rounds

Alternatives to Bishop Score for Predicting Induction Failure?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Kamel et al. (AJOG, 2021) assessed the feasibility of developing and validating transabdominal and transperineal ultrasound for the prediction of cesarean delivery for failure to progress among women who are being induced

METHODS:

  • Prospective observational cohort study
  • Participants
    • Primigravidae | Singleton term pregnancies | Cephalic presentation
    • Exclusion: Operative delivery for fetal distress or indications other than failure to progress in labor
  • Exposure
    • Baseline Bishop scoring
    • Transabdominal and transperineal ultrasound assessments of the fetus, maternal cervix, and pelvic floor
  • Study design
    • Managing obstetricians were blind to the ultrasound findings
    • The participants were divided into a model development group and a cross-validation group
    • Following enrollment
      • Transabdominal scan: Fetal biometry | Fetal occiput position
      • Transperineal scan: Cervical length | Angle of progression (parameter for the assessment of the descent of the fetal head) AP diameter of the levator hiatus | Head-to-perineum distance | Head-to-symphysis distance
  • Primary outcome
    • Cesarean delivery following induction for failure to progress

RESULTS:

  • 243 women in model development group | 101 in cross-validation group
  • The following were found to be independent predictive variables for cesarean delivery
    • Maternal age: odds ratio 1.12 (P = 0.003)
    • Cervical length: OR 1.08 (P = 0.04)
    • Angle of progression: OR 0.9 (P = 0.001)
    • Occiput posterior position: OR 5.7 (P = 0.006)
  • AUC for ability of the model to predict cesarean delivery
    • Developed model: 0.7969 (95% CI, 0.71 to 0.87)
    • Validated model: 0.88 (95% CI, 0.79 to 0.97)

CONCLUSION:

  • This study identified a combination of maternal age and ultrasound measurements obtained during induction that were good at predicting cesarean delivery due to failure to progress following induction of labor
  • Digital examination can be inaccurate, especially with molding and/or caput 
  • The authors state

On external validation, this prediction model has the potential to be a useful tool for clinicians and women to make management plans and informed healthcare choices by providing them with the individualized risk of cesarean delivery

Learn More – Primary Sources:

Predicting cesarean delivery for failure to progress as an outcome of labor induction in term singleton pregnancy

Role of intrapartum transperineal ultrasound: Angle of progression cut-off and correlation with delivery mode

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Practical info on evidence based medicine for your women's healthcare practice
Labor Induction and an Unripe Cervix: Does it Result in More C-sections?
A New Predictive Model for Successful Induction of Labor
Can the Cesarean Prediction Calculator Also Predict Labor Length and Morbidity?

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site